Nuclear receptors in metabolic diseases

Author： Mukherjee R. Saye J.A. Young P.R.

ISSN： 1472-8222

Source： Expert Opinion on Therapeutic Targets, Vol.4, Iss.3, 2000-06, pp. : 377-396

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Metabolic and Efflux Properties of Caco-2 Cells Stably Transfected with Nuclear Receptors

By Korjamo Timo Mönkkönen Jukka Uusitalo Jouko Turpeinen Miia Pelkonen Olavi Honkakoski Paavo

Pharmaceutical Research, Vol. 23, Iss. 9, 2006-09 ,pp. : 1991-2001

Springer Publishing Company

Access to resources Recommend Favorite

Targeting orphan nuclear receptor SHP in the treatment of metabolic diseases

By Kim Mi-Kyung Chanda Dipanjan Lee In-Kyu Choi Hueng-Sik Park Keun-Gyu

Expert Opinion on Therapeutic Targets, Vol. 14, Iss. 4, 2010-04 ,pp. : 453-466

Informa Healthcare

Access to resources Recommend Favorite

Nuclear membrane receptors and channels as targets for drug development in cardiovascular diseases

By Bkaily Ghassan Avedanian Levon Jacques Danielle

Canadian Journal of Physiology and Pharmacology, Vol. 87, Iss. 2, 2009-02 ,pp. : 108-119

NRC Research Press

Access to resources Recommend Favorite

New Insights on the Xenobiotic-Sensing Nuclear Receptors in Liver Diseases- CAR and PXR-

Current Drug Metabolism, Vol. 9, Iss. 7, 2008-09 ,pp. : 614-621

Bentham Science Publishers

Access to resources Recommend Favorite

PPAR Modulators and PPAR Pan Agonists for Metabolic Diseases: The Next Generation of Drugs Targeting Peroxisome Proliferator-Activated Receptors?

Current Topics in Medicinal Chemistry, Vol. 8, Iss. 9, 2008-06 ,pp. : 728-749

Bentham Science Publishers

Access to resources Recommend Favorite